Clinical Trial Update: Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1 and Phase 2 trials evaluating tadalafil and nesiritide as therapy in pre-clinical heart failure; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))
• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Mayo Clinic | Conditions: Congestive Heart Failure | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-04